You are here
Home > 2019 > April > 17

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Press Release: 17 April 2019

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Polling Results Show Widodo Leading Indonesia Election

Polling groups said Wednesday that Indonesian President Joko Widodo is ahead in the country's presidential election.

The so-called quick counts based on data collected at polling stations showed Widodo about 10 percentage points ahead of challenger Prabowo Subianto.

Indonesia's Election …

Top